7 Results for "

12-Deoxywithastramonolide

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "12-Deoxywithastramonolide" in MCE Product Catalog:

Cat. No.: HY-N7195
CAS No.: 60124-17-6
12-Deoxywithastramonolide is a principle bioactive compound found in ashwagandha (W. somnifera). 12-Deoxywithastramonolide possesses antioxidant and enzyme inhibitory effects .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-17365
CAS No.: 79517-01-4
Synonyms: SMS 201-995 acetate
Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.
loading...
    loading...
Cat. No.: HY-N7195R
CAS No.: 60124-17-6
12-Deoxywithastramonolide (Standard) is the analytical standard of 12-Deoxywithastramonolide. This product is intended for research and analytical applications. 12-Deoxywithastramonolide is a principle bioactive compound found in ashwagandha (W. somnifera). 12-Deoxywithastramonolide possesses antioxidant and enzyme inhibitory effects .
loading...
    loading...
Cat. No.: HY-P11032
CAS No.: 3106022-48-1
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Mp-4D7-pF2, a cell-penetrating bicyclic peptide, is a noncovalent SARS-CoV-2 main protease inhibitor with an IC50 of 4.51 μM. Mp-4D7-pF2 has an antiviral activity against SARS-CoV-2 with no cytotoxicity. Mp-4D7-pF2 can used for COVID-19 infections research .
loading...
    loading...
Cat. No.: HY-P5443
CAS No.: 224569-84-0
Target:  

Bacterial

Research Areas:  

Others

Pyrrhocoricin is a biological active peptide. (Antimicrobial activity against Gram-negative bacteria)
loading...
    loading...
Cat. No.: HY-P1696
CAS No.: 114376-16-8
Target:  

Renin

Research Areas:  

Cardiovascular Disease

U 70714E is a Renin inhibitor with an IC50 of 3.0 nM. U 70714E is used for the research of renin-related hypertension .
loading...
    loading...
Cat. No.: HY-P3252AS
Pegcetacoplan- 13C3, 15N TFA is the 13C- and 15N-labeled Pegcetacoplan TFA. Pegcetacoplan is a pegylated complement C3/C3b inhibitor. Pegcetacoplan acts by specifically binding to and inhibiting C3 and C3b, thereby suppressing the complement cascade at its proximal stage. Pegcetacoplan is not a known inhibitor or inducer of CYP450 isoenzymes. Pegcetacoplan can be used for the research of complement-mediated diseases, including paroxysmal nocturnal hemoglobinuria (PNH) and age-related macular degeneration (AMD).
loading...
    loading...